Articles with public access mandates - Prof. Dr. Edgar Dahl (PhD)Learn more
Not available anywhere: 6
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer
E Dahl, G Kristiansen, K Gottlob, I Klaman, E Ebner, B Hinzmann, ...
Clinical Cancer Research 12 (13), 3950-3960, 2006
Mandates: German Research Foundation
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection
HE Wasmuth, MM Zaldivar, ML Berres, A Werth, D Scholten, S Hillebrandt, ...
Journal of hepatology 48 (2), 208-215, 2008
Mandates: German Research Foundation
Intermediate filament dynamics and breast cancer: Aberrant promoter methylation of the Synemin gene is associated with early tumor relapse
E Noetzel, M Rose, E Sevinc, RD Hilgers, A Hartmann, A Naami, ...
Oncogene 29 (34), 4814-4825, 2010
Mandates: German Research Foundation
ITIH5 induces a shift in TGF‐β superfamily signaling involving endoglin and reduces risk for breast cancer metastasis and tumor death
M Rose, SK Meurer, V Kloten, R Weiskirchen, B Denecke, ...
Molecular carcinogenesis 57 (2), 167-181, 2018
Mandates: German Research Foundation
Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is a natural stabilizer of hyaluronan that modulates biological processes in the skin
S Huth, L Huth, Y Marquardt, K Fietkau, E Dahl, PR Esser, SF Martin, ...
Skin Pharmacology and Physiology 33 (4), 198-206, 2020
Mandates: US National Institutes of Health, German Research Foundation
The atypical cadherin Dachsous1 localizes to the base of the ciliary apparatus in airway epithelia
C Dau, M Fliegauf, H Omran, M Schlensog, E Dahl, CR van Roeyen, ...
Biochemical and Biophysical Research Communications 473 (4), 1177-1184, 2016
Mandates: German Research Foundation
Available somewhere: 45
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
H Lue, M Thiele, J Franz, E Dahl, S Speckgens, L Leng, ...
Oncogene 26 (35), 5046-5059, 2007
Mandates: German Research Foundation
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J Veeck, D Niederacher, H An, E Klopocki, F Wiesmann, B Betz, O Galm, ...
Oncogene 25 (24), 3479-3488, 2006
Mandates: German Research Foundation
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis
A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ...
BMC cancer 8, 1-15, 2008
Mandates: Canadian Institutes of Health Research, German Research Foundation
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans
HE Wasmuth, F Lammert, MM Zaldivar, R Weiskirchen, C Hellerbrand, ...
Gastroenterology 137 (1), 309-319. e3, 2009
Mandates: US National Institutes of Health, German Research Foundation
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
E Verjans, E Noetzel, N Bektas, AK Schütz, H Lue, B Lennartz, ...
BMC cancer 9, 1-18, 2009
Mandates: German Research Foundation
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
N Bektas, A Haaf, J Veeck, PJ Wild, J Lüscher-Firzlaff, A Hartmann, ...
BMC cancer 8, 1-9, 2008
Mandates: German Research Foundation
Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival
A Ten Haaf, N Bektas, S Von Serenyi, I Losen, EC Arweiler, A Hartmann, ...
BMC cancer 9 (1), 298, 2009
Mandates: German Research Foundation
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E Dahl, F Wiesmann, M Woenckhaus, R Stoehr, PJ Wild, J Veeck, ...
Oncogene 26 (38), 5680-5691, 2007
Mandates: German Research Foundation
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
J Veeck, PJ Wild, T Fuchs, PJ Schüffler, A Hartmann, R Knüchel, E Dahl
BMC cancer 9, 1-13, 2009
Mandates: German Research Foundation
Epigenetic inactivation of the secreted frizzled-related protein-5 ( SFRP5 ) gene in human breast cancer is associated with unfavorable prognosis
J Veeck, C Geisler, E Noetzel, S Alkaya, A Hartmann, R Knüchel, E Dahl
Carcinogenesis 29 (5), 991-998, 2008
Mandates: German Research Foundation
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
N Bektas, E Noetzel, J Veeck, MF Press, G Kristiansen, A Naami, ...
Breast Cancer Research 10, 1-12, 2008
Mandates: German Research Foundation
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours
J Veeck, N Bektas, A Hartmann, G Kristiansen, U Heindrichs, R Knüchel, ...
Breast Cancer Res 10 (5), R82, 2008
Mandates: German Research Foundation
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
J Veeck, E Noetzel, N Bektas, E Jost, A Hartmann, R Knüchel, E Dahl
Molecular Cancer 7, 1-19, 2008
Mandates: German Research Foundation
The Bayesian group-Lasso for analyzing contingency tables
S Raman, TJ Fuchs, PJ Wild, E Dahl, V Roth
Proceedings of the 26th Annual International Conference on Machine Learning …, 2009
Mandates: Swiss National Science Foundation
Publication and funding information is determined automatically by a computer program